EQUILLIUM, INC. Accumulated Other Comprehensive Income
EQUILLIUM, INC. (EQ) had Accumulated Other Comprehensive Income of $381.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $381.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $370.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $363.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $270.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $381.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $370.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $363.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $270.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $385.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $731.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $781.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$3.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $251.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $423.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $140.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $458.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $340.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $305.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $76.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $193.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$149.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$454.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$138.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$66.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$209.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$255.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$297.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | -$30.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $97.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $474.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $21.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $80.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $87.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $49.00K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $5.00K 10-K · filed 2020-03-26 | $5.28K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |